In March 2026, Agilent Technologies saw the Supreme Court deny its petition in a long-running CRISPR patent case, while also ...

Crispr Therapeutics AG looks set for 2026 revenue inflection as Casgevy ramps; strong efficacy, undervalued shares, robust ...

Synthego, a pioneering leader in genome engineering solutions, today announced that the Supreme Court of the United States has denied a petition for a writ of certiorari from Agilent Technologies, Inc ...

A US patent board last week backed the Broad Institute’s claim to CRISPR use in human and animal cells, not the Nobel winners ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

Any molecular biologist will tell you that genetic engineering is tricky. But up until recently we might be witnessing a new ...

Most people who have heard of clustered regularly interspaced short palindromic repeats (more commonly known as CRISPR) associate it with gene editing—the precise molecular scissors that allow ...

Anthropic’s leaked Claude Operon adds a life-sciences workspace in its desktop app, supporting CRISPR design, RNA-seq ...

More than 60 years after its discovery, scientists are still learning surprising ways DNA stores and translates instructions ...

The gene therapy regimen seems to be working wonders, including restoring nearly all hearing to a seven-year-old patient ...

Two research teams mined genomic data from bacteria to create databases containing thousands of antiviral defence proteins ...

Bacterial immune systems protect against viral invaders called phages by precisely targeting specific phage genetic sequences ...